Cite
HARVARD Citation
Funt, S. et al. (2022). Neoadjuvant Atezolizumab With Gemcitabine and Cisplatin in Patients With Muscle-Invasive Bladder Cancer: A Multicenter, Single-Arm, Phase II Trial. Journal of clinical oncology. 40 (12), pp. 1312-1322. [Online].